Nishi Shah, MD, MBBS
Remarkable progress has been made in the treatment of myeloma over the past decade, giving patients and families much hope for the future. In this episode, we speak to Dr. Nishi Shah of Montefiore Einstein Comprehensive Cancer Center in New York City. While the wide variety of therapies available to patients are discussed, this episode also focuses on the newest, cutting-edge therapies for myeloma, such as CAR T-cell therapy and bispecific antibodies.
Podcast: Play in new window | Download
Subscribe: Google Podcasts | Spotify | Pandora | Blubrry | JioSaavn | Podchaser | More
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- Multiple Myeloma
- CAR T-cell Therapy
- Bispecific Antibodies – Immunotherapy Booklet
- Stem Cell Transplant
- Multiple Myeloma and Agent Orange
Additional LLS Support Resources:
- Information Specialists
- Financial support
- Free telephone/web patient programs
- Free booklets
- Clinical Trial Support Center
- Young Adult Resources
- Caregiver support
- Caregiver Workbook
- Survivorship Workbook
- Online chats
- LLS Community
- Support groups
- Patti Robinson Kaufmann First Connection Program
- Free Nutrition Consultations
Support for this episode provided by: AbbVie Inc.; Genentech, Inc. & Biogen; and Johnson & Johnson.
Very informative, I’m glad I chose to view it.
I’m a fairly new Waldenstrom patient, but see a lot of similarities within the Multiple Myeloma area.
Thank you for offering this.
Thank you. This is one of the most concise explanations that I have heard to date. I was diagnosed 4/2023 and I have hope!